This is the authors' abstract. We don't add key points for this paper.
Background/Aim: Cancer stem cells (CSCs) are heterogeneous and exhibit distinct phenotypic and functional characteristics. The side population (SP) and CD44+/CD24− phenotypes are widely used to enrich breast cancer cells with CSC-associated properties; however, whether these approaches identify functionally equivalent populations remains unclear. Building on our previous establishment of a DyeCycle Violet (DCV)-based method for isolating SP cells from MCF-7 breast cancer cells, this study compared the biological characteristics of DCV-defined SP cells and a CD44+/CD24−-enriched fraction. Materials and Methods: SP cells were isolated from MCF-7 cells by fluorescence-activated cell sorting using DCV and fumitremorgin C. A CD44+/CD24−-enriched fraction was isolated by magnetic-activated cell sorting. Parental MCF-7 cells, SP cells, and the CD44+/CD24−-enriched fraction were compared for proliferation and invasion. Tumor-forming ability was evaluated in nude mice following subcutaneous inoculation of 100 or 500 cells. Xenograft tumors were examined histopathologically and immunohistochemically. Results: No significant differences in proliferative activity were observed among parental MCF-7, SP, and the CD44+/CD24−-enriched fraction at either 48 or 72 h. Invasion was highest in the CD44+/CD24−-enriched fraction (87.63±20.29%), followed by SP cells (51.86±6.83%) and parental MCF-7 cells (32.52±9.95%; p=0.001). Tumors developed in all three mice receiving the CD44+/CD24−-enriched fraction at both cell doses, whereas tumor formation was less frequent in the other groups. Xenograft tumors showed morphological and immunohistochemical characteristics consistent with MCF-7 cells. Conclusion: DCV-defined SP cells and the CD44+/CD24−-enriched fraction exhibited distinct biological characteristics. The CD44+/CD24−-enriched fraction showed high invasive activity and frequent tumor formation, whereas SP cells showed relatively high proliferative activity and retained tumor-forming capacity under the experimental conditions examined. These findings suggest that SP and CD44+/CD24− enrichment methods select populations with different functional properties.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
OSAWA et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: